05.11.2019 • TopicsCloudDassault SystemesWebinar

Expert-Webinar: How to Elevate your Lab to the Cloud

©totojang1977/Shutterstock
©totojang1977/Shutterstock

Life sciences organizations need to optimize operations by improving efficiency and adhere to regulations while driving innovations. These challenges also apply to the lab environment, which needs to remove both inefficiencies and compliance risks and provide a collaborative environment for innovation.

If you’re keen to discover how a digital lab can enable end-to-end digital workflows and leverage digital continuity throughout the entire product life-cycle management, then you need to join this webinar, presented by Wiley and Dassault Systèmes:

 

Register to attend the on-demand version of the webinar.

 

Some of your key learnings will be:

  • Key Industry Drivers pushing labs toward end-to-end digital workflows
  • How the cloud enables and accelerates transformation in Life Sciences
  • How mobile procedure and method execution supports the full lab workflow

 

Please visit this website to receive further insights.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.